Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein e knockout mice

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 121-130

  Prins, Petra A ^a   Perati, Prudhvidhar R ^a   Kon, Valentina ^a   Guo, Zhongmao ^c   Ramesh, Aramandla ^c   Linton, MacRae F ^a,b   Fazio, Sergio ^a,b   Sampson, Uchechukwu K ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Abdominal aortic aneurysm; ApoE deficient mice; Benzo a pyrene; Environmental toxicants; Inflammation; Proteolysis

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; BENZO[A]PYRENE; CYCLOPHILIN A; GELATINASE B; POLYCYCLIC AROMATIC HYDROCARBON; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; POLLUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

MUS;

EID: 84859838216     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337593     Document Type: Article

References (61)

1. Gillum RF: Epidemiology of aortic aneurysm in the United States. J of Clin Epidemiol 1995;48:1289-1298.
2. Blanchard JF, Armenian HK, Friesen PP: Risk Factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000;151:575-583. (Pubitemid 30463602)
3. Blanchard JF: Epidemiology of abdominal aortic aneurysms. Epidemiol Rev 1999;21:207-221. (Pubitemid 30649823)
4. Thompson MM: Controlling the expansion of abdominal aortic aneurysms. Br J Surg 2003;90:897-898. (Pubitemid 37026316)
5. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26: 987-994. (Pubitemid 43732102)
6. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-1151.
7. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD: Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994;90:II224-227. (Pubitemid 24349275)
8. Thompson RW, Geraghty PJ, Lee JK: Abdominal aortic aneurysms: basic mechanisms and clinical implications. Current Prob Surg 2002;39:110-230.
9. Thomas M, Gavrila D, McCormick ML, Miller FJ Jr, Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL: Deletion of p47phox attenuates angiotensin IIInduced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 2006;114:404-413. (Pubitemid 44264822)
10. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, Pure E, FitzGerald GA: Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 2008;117:1302-1309. (Pubitemid 351365673)
11. Albert RE, Vanderlaan M, Burns FJ, Nishizumi M: Effect of carcinogens on chicken atherosclerosis. Cancer Res 1977;37:2232-2235.
12. Paigen B, Holmes PA, Morrow A, Mitchell D: Effect of 3-Methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res 1986;46:3321-3324. (Pubitemid 16096864)
13. Curfs DMJ, Lutgens E, Gijbels MJJ, Kockx MM, Daemen MJAP, van Schooten FJ: Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoEknockout mice. Am J Pathol 2004;164:101-108. (Pubitemid 38364595)
14. Batastini G, Penn A: An ultrastructural comparison of carcinogen-associated and spontaneous aortic lesions in the cockerel. Am J Pathol 1984;114:403-409. (Pubitemid 14151577)
15. Penn A, Snyder C: Arteriosclerotic plaque development is promoted by polynuclear aromatic hydrocarbons. Carcinogenesis 1988;9:2185-2189. (Pubitemid 19001317)
16. Anyakora C, Arbabi M, Coker H: A screen for benzo(a)pyrene in fish samples from crude oil polluted environments. Am JEnviron Sci 2008;4:145-150. (Pubitemid 351225565)
17. World Health Organization: Some nonheterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monographs on the evaluation of the carcinogenic risks to humans. Geneva, Switzerland 2010, vol 92, pp 1-861.
18. Ramesh A, Archibong AE, Hood DB, Guo Z, Loganathan BG: Global Environmental distribution and human health effects of polycyclic aromatic hydrocarbons; in Loganathan BG, Lam PK-S (eds): Global Contamination Trends of Persistent Organic Chemicals. Boca Raton, Florida, CRC Press 2011, pp 95-124.
19. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E deficient mice. J Clin Invest 2000;105:1605-1612. (Pubitemid 30390311)
20. Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms Arterioscler, Thromb Vasc Biol 2004;24:429-434 (Pubitemid 38326134)
21. Yang H ZL, Wang Z, Roberts LJ 2nd, Lin X, Zhao Y, Guo Z: Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses benzo(a) pyreneaccelerated atherosclerosis. Atherosclerosis 2009;207:51-58.
22. Revis NW, Bull R, Laurie D, Schiller CA: The effectiveness of chemical carcinogens to induce atherosclerosis in the white Carneau pigeon. Toxicology 1984;32:215-227. (Pubitemid 14060754)
23. Sampson UK, Perati PP, Prins PA, Pham W, Liu Z, Harrell Jr FE, Linton MF, Gore JC, Kon V, Fazio S: Quantitative estimates of variability of in vivo ultrasound imaging measurements of mouse aorta important for studies of abdominal aortic aneurysms and related arterial diseases. J Ultrasound Med 2011;30:773-784.
24. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF: Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Nat Acad Sci USA 1997;94:4647-4652. (Pubitemid 27194297)
25. Bond JA, Gown AM, Yang HL, Benditt EP, Juchau MR: Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health 1981;7:327-335. (Pubitemid 11130457)
26. van Schanke A, Holtz F, van der Meer J, Boon JP, Ariese F, Stroomberg G, van den Berg M, Everaarts JM: Dose-and time-dependent formation of biliary benzo[a]pyrene metabolites in the marine flatfish Dab (Limanda limanda). Environ Toxicol Chem 2001;20:1641-1647. (Pubitemid 32674597)
27. Leadly TA, Arcand-Hoy LD, Haffner GD, Metcalfe CD: Fluorescent aromatic hydrocarbons in bile as a biomarker of exposure of brown bullheads (Ameiurus nebulosus) to contaminated sediments. Environ Toxicol Chem 1999;18:750-755.
28. Collier TK, Varanasi U: Hepatic activities of xenobiotic metabolizing enzymes and biliary levels of xenobiotics in English Sole (Parophrys vetulus) exposed to environmental contaminants. Arch Environl Contam Toxicol 1991;20:462-473.
29. Beyer J, Sandvik M, Skare JU, Egaas E, Hylland K, Waagbo R, Goksoyr A. Timeand dose-dependent biomarker responses in flounder (Platichthys flesus L.) exposed to benzo[a]pyrene, 2,3,3′,4,4′,5-hexachlorobiphenyl (PCB-156) and cadmium. Biomarkers 1997;2:35-44. (Pubitemid 127699882)
30. Willett K, Steinberg M, Thomsen J, Narasimhan TR, Safe S, McDonald S, Beatty K, Kennicutt MC: Exposure of killifish to benzo[a]pyrene: comparative metabolism, DNA adduct formation and aryl hydrocarbon (Ah) receptor agonist activities. Comp Biochem Physiol Part B: Biochem Mol Biol 1995;112:93-103.
31. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V: Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis 2006;184:312-321. (Pubitemid 43049715)
32. Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, Tao H, Erbay E, Gorgun CZ, Fazio S, Hotamisligil GS, Linton MF: Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-(gamma) regulated genes. Arterioscler Thromb Vasc Biol 2001;31:1283-1290.
33. Kon V, Linton MF, Fazio S: Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol 2011;7:45-54.
34. Babaev VR, Whitesell RR, Li L, Linton MF, Fazio S, May JM: Selective macrophage ascorbate deficiency suppresses early atherosclerosis. Free Radic Biol Med 2011;50:27-36.
35. Babaev VR, Li L, Shah S, Fazio S, Linton MF, May JM: Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein Edeficient mice. Arterioscler Thromb Vasc Biol 2010;30:1751-1757.
36. Babaev VR, Chew JD, Ding L, Davis S, Breyer MD, Breyer RM, Oates JA, Fazio S, Linton MF: Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 2008;8:492-501.
37. Babaev VR, Porro F, Linton MF, Fazio S, Baralle FE, Muro AF: Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 2008;197:534-540. (Pubitemid 351417892)
38. Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S: Increased cholesterol efflux in Apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) Mice. Arterioscler Thromb Vasc Biol 2001;21:1790-1795. (Pubitemid 34223450)
39. Taniyama Y, Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003;42:1075-1081. (Pubitemid 37549058)
40. Griendling KK, FitzGerald GA: Oxidative Stress and cardiovascular injury: Part II: Animal and human studies. Circulation 2003;108:2034-2040. (Pubitemid 37337574)
41. Satoh K, Nigro P, Matoba T, O'Dell MR, Cui Z, Shi X, Mohan A, Yan C, Abe J-i, Illig KA, Berk BC: Cyclophilin A enhances vascular oxidative stress and the development of angiotensin IIinduced aortic aneurysms. Nat Med 2009;15:649-656.
42. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA: Angiotensin II accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003;112:1318-1331. (Pubitemid 38057686)
43. Hellenthal FAMVI, Buurman WA, Wodzig WKWH, Schurink GWH: Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation. Nat Rev Cardiol 2009;6:543-552.
44. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC: Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000;87:789-796.
45. Liao DF, Jin ZG, Baas AS, Daum G, Gygi SP, Aebersold R, Berk BC: Purification and Identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 2000;275:189-196. (Pubitemid 30038971)
46. Satoh K, Matoba T, Suzuki J, O'Dell MR, Nigro P, Cui Z, Mohan A, Pan S, Li L, Jin ZG, Yan C, Abe JI, Berk BC: Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 2008;117:3088-3098.
47. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, Tilson MD: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-820. (Pubitemid 24365295)
48. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD: Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1994;14:1315-1320.
49. Nishimura K IM, Kanaoka Y, Ohgi S, Ueta E, Nanba E, Ito H.: Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Int Angiol 2003;22:229-238. (Pubitemid 37483692)
50. Yoshimura K, Aoki H, Ikeda Y, Furutani A, Hamano K, Matsuzaki M: Regression of Abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice Ann NY Acad Sci 2006;1085:74-81
51. Hellenthal FAMVI, Buurman WA, Wodzig WKWH, Schurink GWH: Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol 2009;6:464-474.
52. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26:987-994. (Pubitemid 43732102)
53. Hellenthal FAMVI, Geenen ILA, Teijink JAW, Heeneman S, Schurink GWH: Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc Pathol 2009;18:286-293.
54. Juvonen J, Surcel H-M, Satta J, Teppo AM, Bloigu A, Syrjala H, Airaksinen J, Leinonen M, Saikku P, Juvonen T: Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997;17:2843-2847. (Pubitemid 28016030)
55. Burdick AD, Davis JW, Liu KJ, Hudson LG, Shi H, Monske ML, Burchiel SW: Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res 2003;63:7825-7833. (Pubitemid 37466715)
56. Flowers L, Bleczinski WF, Burczynski ME, Harvey RG, Penning TM: Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase. Biochemistry 1996;35:13664-13672. (Pubitemid 26359179)
57. Kerzee JK, Ramos KS: Activation of c-Ha-ras by Benzo(a)pyrene in vascular smooth muscle cells involves redox stress and aryl hydrocarbon receptor. Mol Pharmacol 2000;58:152-158. (Pubitemid 30452538)
58. Kim HS, Kwack SJ, Lee BM: Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. Chem-Biol Interact 2000;127:139-150. (Pubitemid 30599479)
59. Penning TM, Ohnishi ST, Ohnishi T, Harvey RG: Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem Res Toxicol 1996;9:84-92. (Pubitemid 26041277)
60. Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A, Guo ZM: Retardation of atherosclerosis by overexpression of catalase or both Cu/ Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004;95:1075-1081. (Pubitemid 39557894)
61. Zhang Y, Ramos KS: The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene. Vasc Health Risk Manag 2008;4:1095-1102.